CCL2 and neoplasm: Notably, IL-6 can elevate the levels of EIF4A3 and CCL2 in tumor cells via activation of the JAK2/STAT3 pathway, further facilitating tumor cSERPINE2 biogenesis and inducing TAMs recruitment [79].